The Company has engineered a new 3D-printed swab design and has trademarked the name CANSWAB™ for distribution. The collection capability has been clinically tested and proven statistically equivalent to a traditional flocked swab. The Company received Health Canada approval for the CANSWAB™ design on June 23, 2020.
Precision ADM has secured an additional 20,000 square foot facility in order to build the needed cleanroom manufacturing areas for mass-producing nasopharyngeal swabs. With the added capabilities and facilities, the Company will be able to manufacture and ship hundreds of thousands of CANSWAB™ nasopharyngeal swabs per week.